DEMOGRAPHIC FACTORS ASSOCIATED WITH ORAL CONTRACEPTIVE USE IN KOREAN WOMEN
Keywords:
Oral contraceptive, Prevalence, Demographics, KNHANESAbstract
Objective: We determined the prevalence of oral contraceptive (OC) use and the demographic factors associated with OC use in Korean women.
Methods: A descriptive epidemiologic study was conducted using data for women aged 20-54 y collected by the 2005-2009 Korea National Health and Nutrition Examination Surveys. OC use and demographic characteristics were obtained from the participants by questionnaire.
Results: During the study period, the prevalence of OC use ranged from 14.8% to 16.0%. Longer duration of OC use was positively associated with age and with increased cigarette smoking and decreased education. However, the use of OCs was not associated with body mass index, household income, alcohol drinking, or regular exercise.
Conclusion: Oral contraceptives are used widely by Korean women, and their use is associated with several demographic factors.
Keywords: Oral contraceptive, Prevalence, Demographics, KNHANES
Downloads
References
Chandra A, Martinez GM, Mosher WD, Abma JC, Jones J. Fertility, family planning, and reproductive health of US women: data from the 2002 National Survey of Family Growth. Vital Health Stat 2005;12:1-160.
Benagiano G, Bastianelli C, Farris M. Contraception today. Ann N Y Acad Sci 2006;1092:1-32.
United Nations, Department of Economic and Social Affairs, Population Division. The World contraceptive use; 2011. Available From: http://www.un.org/ esa/population/ publications/ contraceptive 2011/contraceptive2011.htm. [Last accessed on 14 Mar 2016].
Mosher WD, Jones J. Use of contraception in the United States: 1982-2008. Vital Health Stat 2010;23:1-43.
Edelman A, Micks E, Gallo MF, Jensen JT, Grimes DA. Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception. Cochrane Database Systematic Rev 2014;7:CD004695. Doi:10.1002/ 14651858. CD004695. [Article in Press]
Gallo MF, Nanda K, Grimes DA, Lopez LM, Schulz KF. 20 µg versus>20 µg estrogen combined oral contraceptives for contraception. Cochrane Database Systematic Rev 2013;8: CD003989. Doi:10.1002/14651858.CD003989. [Article in Press]
Burkman R, Bell C, Serfaty D. The evolution of combined oral contraception: improving the risk-to-benefit ratio. Contraception 2011;84:19-34.
Van Vliet HA, Grimes DA, Lopez LM, Schulz KF, Helmerhorst FM. Triphasic versus monophasic oral contraceptives for contraception. Cochrane Database of Systematic Rev 2011;11: CD003553. Doi:10.1002/14651858.CD003553. [Article in Press]
Lawrie TA, Helmerhorst FM, Maitra NN, Kulier R, Bloemenkamp K, Gulmezoglu AM. Types of progestogens in combined oral contraception: effectiveness and side-effects. Cochrane Database of Systematic Rev 2011;5:CD004861. Doi:10.1002/14651858.CD004861. [Article in Press]
Maitra NN, Kulier R, Bloemenkamp K, Helmerhorst FM, Gulmezogul AM. Progestogens in combined oral contraceptives for contraception. Cochrane Database of Systematic Rev 2004;3:CD004861.
Carrasco-Garrido P, Jiménez-GarcÃa R, Barrera VH, Gil de Miguel A. Predictive factors of self-medicated drug use among the Spanish adult population. Pharmacoepidemiol Drug Saf 2008;17:193-9.
Paulose-Ram R, Jonas BS, Orwig D, Safran MA. Prescription psychotropic medication use among the U. S. adult population: results from the third national health and nutrition examination survey, 1988-1994. J Clin Epidemiol 2004;57:309-17.
Caamaño F, Figueiras A, Lado E, Gestal-Otero JJ. Selfmedication: concept and users’†profile. Gaceta Sanitaria 2000;14:294-9.
Mosher WD, Martinez GM, Chandra A, Abma JC, Willson SJ. Use of contraception and use of family planning services in the United States: 1982-2002. Adv Data 2004;350:1-36.
Lete I, Dueñas JL, MartÃnez-Salmeán J, Parrilla JJ, Serrano I, Bermejo R, et al. Contraceptive practices and trends in Spain: 1997-2003. Eur J Obstet Gynecol Reprod Biol 2007;135:73-5.
Day NE, Wong MY, Bingham S, Khaw KT, Luben R, Michels KB, et al. Correlated measurement error--implications for nutritional epidemiology. Int J Epidemiol 2004;33:1373-81.